Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Factor (LITAF) Peptide

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Factor (LITAF) Peptide is a synthetic peptide.
Documents del producto
Product specifications
Category | Proteins and Peptides |
Immunogen Target | Lipopolysaccharide-Induced Tumor Necrosis Factor-Alpha Factor (LITAF) |
Host | Synthetic |
Recommended Dilution | BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Observed MW | Sequence Fragment: Internal region: C-PDGKGMNPPSYYTQ |
Size 1 | 100 µg |
Form | Lyophilized Reconstitute in deionized water. |
Tested Applications | P-ELISA |
Buffer | Prior to lyophilization: Deionized water. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
Gene ID | 9516, 56722, 65161 |
NCBI Accession | NP_004853.2, NP_001129945.1 |
Background | Protein LITAF |
Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
Related Products

Human LITAF (Lipopolysaccharide-induced tumor necrosis factor-alpha factor) ELISA Kit
Ver Producto
Mouse LITAF (Lipopolysaccharide-induced tumor necrosis factor-alpha factor) ELISA Kit
Ver Producto
LITAF antibody
Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene.
Ver Producto